Clinical Trials on Human Metapneumovirus (hMPV) Infection

Total 7542 results

National Institute of Allergy and Infectious Diseases...

Completed

Safety Study of a Human Metapneumovirus Challenge Virus in Healthy Adults

Human Metapneumovirus

United States
ModernaTX, Inc.

Recruiting

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

Respiratory Syncytial Virus | Human Metapneumovirus

United Kingdom, Spain, United States, Australia, Canada, Poland, South Africa, Panama
AlloVir

Terminated

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Influenza Infection | Respiratory Tract Viral Infections | Human Metapneumovirus (hMPV) Infection | Parainfluenza (PIV) Infection | Respiratory Syncytial Viral (RSV) Infection

United States
ModernaTX, Inc.

Completed

Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults

Human Metapneumovirus and Human Parainfluenza Infection

United States
ModernaTX, Inc.

Active, not recruiting

Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure

Human Metapneumovirus and Human Parainfluenza Infection

United States
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

Healthy Volunteers | Respiratory Syncytial Virus Infection | Human Metapneumovirus

United States, Puerto Rico
Assistance Publique - Hôpitaux de Paris

Unknown

Clinical Features, Outcome and Prognosis of Human Metapneumovirus (hMPV) Lower Respiratory Tract Infections in Adult Inpatients (French-hMPV)

Lower Resp Tract Infection | Human Metapneumovirus Infection

France
Imperial College London
Sense Biodetection Limited

Unknown

Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens (SIMPLIFI)

Enterovirus Infections | Respiratory Syncytial Virus Infections | Human Influenza | Rhinoviral Infections | Metapneumovirus Infection | Parainfluenzae Viral Infections

United Kingdom
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.

Human Papillomavirus (HPV) Infection

Senegal, Tanzania
University College, London
Public Health England

Completed

Specific Respiratory Infections as Triggers of Acute Medical Events

Cardiovascular Diseases | Influenza, Human | Respiratory Syncytial Virus Infections | Adenovirus | Rhinovirus | Parainfluenza | Human Metapneumovirus Pneumonia

United Kingdom
Merck Sharp & Dohme LLC

Completed

GARDASIL Reexamination Study (V501-059)

Human Papillomavirus (HPV) Infection
Kern Medical Center
Medical Diagnostic Laboratories, LLC; Copan Innovation Murrietta, CA

Unknown

Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses

Influenza | Bronchiolitis | Respiratory Syncytial Virus | Pediatric | Human Metapneumovirus
The Alfred
Merck Sharp & Dohme LLC

Completed

Prevalence of Genital HPV Infection in Males Following Introduction of Universal Male HPV Vaccination (Impress)

Human Papillomavirus

Australia
Klein Buendel, Inc.
National Cancer Institute (NCI); Indiana University; University of New Mexico

Completed

Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake

HPV | Human Papillomavirus Virus

United States
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

Healthy Volunteers | Respiratory Syncytial Virus Infection | Metapneumovirus Infection

Australia, United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Natural History of HPV Infection in Men: The HIM Study

Human Papillomavirus

United States
Monash University
The Alfred; University of Melbourne

Recruiting

Human Papillomavirus in Young People Epidemiological Research 3 (HYPER3)

Cancer | Anal Cancer | HPV Infection | HPV | Human Papillomavirus Infection | Men | HPV 16 Infection

Australia
The University of Texas Health Science Center,...
Baylor College of Medicine; Cancer Prevention Research Institute of Texas

Completed

Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics

Human Papillomavirus (HPV)

United States
Ann & Robert H Lurie Children's Hospital of Chicago

Unknown

Utilization of Human Papillomavirus (HPV) Vaccine Among Young Men Who Have Sex With Men (MSM) and Parents of Boys (Aged 9 to 18 Years)

Human Papillomavirus (HPV)

United States
Monash University
The Alfred; University of Melbourne

Recruiting

Human Papillomavirus in Young People Epidemiological Research 4 (HYPER4)

Cancer | Anal Cancer | HPV Infection | HPV | Human Papillomavirus Infection | Men | HPV 16 Infection

Australia
National Institute for Control of Vaccine and Biologicals

Unknown

Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule (HPV-022 PRI)

Human Papillomavirus (HPV) Vaccine

Vietnam
University of Luebeck
EUROIMMUN Medizinische Labordiagnostika AG

Completed

HPV Infections, Cancer of the Vulva and Therapeutical Success

HPV | Human Papilloma Virus

Germany
QIAGEN Gaithersburg, Inc

Completed

Collection and Testing of Respiratory Samples

Respiratory Syncytial Virus Infections | Influenza A | Rhinovirus | Influenza B | QIAGEN ResPlex II Advanced Panel | Infection Due to Human Parainfluenza Virus 1 | Parainfluenza Type 2 | Parainfluenza Type 3 | Parainfluenza Type 4 | Human Metapneumovirus A/B | Coxsackie Virus/Echovirus | Adenovirus Types B/C/E | Coronavirus Subtypes 229E and other conditions

United States
University of Florida
Patient-Centered Outcomes Research Institute; National Cancer Institute (NCI)

Not yet recruiting

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

Human Papillomavirus (HPV) Vaccines

United States
The Behavioural Insights Team
UNICEF; National Center for Disease Control and Public Health, Georgia; Information...

Not yet recruiting

SMS Reminders to Strengthen Demand for HPV Vaccination in Georgia

HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine
Sinocelltech Ltd.

Recruiting

A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years

HPV Infection Vaccine Safety SCT1000

China
Ulla Bonde van Zwol
University of Southern Denmark; Region of Southern Denmark; MCM Vaccines B.V.

Unknown

Human Papillomavirus and Pregnancy (HPVandPregn)

HPV-infection in Pregnant Women

Denmark
University Hospital, Geneva

Completed

Prevalence of HPV Infection Using Self-sampling

HPV - Anogenital Human Papilloma Virus Infection
Merck Sharp & Dohme LLC

Completed

V501 Efficacy Study in Women Aged 18 to 26 (V501-027)

HPV Infections
University of Alabama at Birmingham

Completed

A Study to Identify Markers in Blood and Tissue of HPV Clearance

HPV Infections

United States
Merck Sharp & Dohme LLC

Suspended

Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)

HPV Infections
Chang Gung Memorial Hospital
Dr. Chip Biotechnology Incorporation

Completed

HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix

Cervical Intraepithelial Neoplasia | HPV Infection | Human Papillomavirus Infection

Taiwan
PDS Biotechnology Corp.

Completed

An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101

High-risk HPV Infection and Biopsy-proven CIN1

United States
University of Pittsburgh
Merck Sharp & Dohme LLC

Completed

Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting

Quadrivalent HPV Vaccine | Human Papillomavirus Vaccine

United States
Ann & Robert H Lurie Children's Hospital of Chicago
Northwestern University; Florida State University

Withdrawn

Increasing Healthcare Engagement Via Routine Vaccination Among Young Black Men Who Have Sex With Men

Hepatitis A | Meningitis | HPV - Anogenital Human Papilloma Virus Infection
The Alfred
Merck Sharp & Dohme LLC

Completed

Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2) (HYPER2)

Human Papillomavirus Infection | Human Papillomavirus

Australia
Merck Sharp & Dohme LLC

Completed

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

HPV Infections
Merck Sharp & Dohme LLC

Completed

An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)

HPV Infections
Shanghai Bovax Biotechnology Co., Ltd.

Completed

A Phase I Study of Quadrivalent HPV Recombinant Vaccine

HPV Infections

China
Merck Sharp & Dohme LLC

Completed

V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)

HPV Infections
Capital Medical University

Unknown

The Standard Management of HPV Infection

the High-Risk HPV Infection

China
The University of Texas Health Science Center,...

Completed

Phase II Evaluation of AHCC for the Eradication of HPV Infections (AHCC4HPV)

Human Papilloma Virus | Dysplasia | CIN1 | CIN2

United States
Kenya Medical Research Institute
Merck Sharp & Dohme LLC; University of Washington

Completed

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

HPV Infection | HPV Vaccine | HIV-1-infection

Kenya
Gilead Sciences

Terminated

Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

Human Papillomavirus (HPV) 16+ Relapsed/Refractory Cancer

United States
National Vaccine and Serum Institute, China
Guangxi Center for Disease Control and Prevention; Simoon Record Pharma Information... and other collaborators

Completed

Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)

HPV Infection | HPV-Related Cervical Carcinoma

China
National Vaccine and Serum Institute, China
Guangxi Center for Disease Control and Prevention; Simoon Record Pharma Information... and other collaborators

Completed

A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

HPV Infection | HPV-Related Cervical Carcinoma

China
Memorial Sloan Kettering Cancer Center

Completed

Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

Human Papillomavirus (HPV)-Related Malignancies | Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

United States
National Taiwan University Hospital

Recruiting

HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy

Hepatitis C Virus Infection | Hepatitis C Virus Infection, Response to Therapy of | Human Immunodeficiency Virus (HIV) Coinfection

Taiwan
University of Florida

Completed

Usability of HPV Vaccine Reminders

Human Papilloma Virus (HPV)

United States
Acibadem University

Completed

Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults

The Prevalance of HMPV After COVID-19 Pandemic | The Importance of Accurate Diagnosis for HPMV

Turkey

Clinical Trials on Human Metapneumovirus (hMPV) Infection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations